Waddill William D. reported option exercise involving 9,000 shares of Protagonist Therapeutics, Inc at $11.80 for $106k on May 29, 2026

Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Director
DIR
Filed Jun 1, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$106,200Shares × reported price
Shares traded
9,000Common Stock
Price per share
$11.80Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
16,825Direct
Trade date
May 29, 2026Option exercise
Filed
Jun 1, 2026, 6:31 PM ET3-day reporting delay
Accession
0001104659-26-069047Code M · Transaction 388048
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
May 29, 2026Option exercise9,000$0.00$0Trade 388050
May 29, 2026Sell9,000$99.64−$896,760Trade 388049
3 transaction rows in this filing. Joint filers share the same rows.

PTGX price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
PTGX · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +3.8%1w ago +4.5%1d ago +5.8%
Returns since7d +3.3%30d +32%90d +52%180d1y

Footnotes in full

F1: The transactions set forth on this Form 4 were effected pursuant to a 10b5-1 plan adopted by the reporting person on February 27, 2026. F2: These stock options are fully vested.